TipRanks

EpicComeback Profile - StockTwits Blogger

4 Followers
tipranks
EpicComeback

EpicComeback
StockTwits

Financial Blogger
#11,989 out of 24,705 Financial Bloggers
#21,271 out of 37,255 experts

Success Rate

50%
12 out of 24 ratings made a profit

Average Return

-1.70%
Average return per rating
Time Frame
1 Year
Compare to
No Benchmark
Copying EpicComeback's trades since 2026 and holding each position for 1 Year would result in 50.00% of your transactions generating a profit, with an average return of -1.7% per rating.

Stock Rating Distribution

24Ratings
66.67% Bearish
33.33% Bullish
0.00% Neutral
Distribution of EpicComeback's ratings

Additional Information

Main Sector:General
Geo Coverage:
United States

Best Rating

Stock:
Moderna
(MRNA)
Rating:Buy
Date:Aug 20, 2026 - Oct 05, 2026
Return:+52.40%
The most profitable rating made by EpicComeback

EpicComeback's Stock Coverage

Company Name
Date
Position
No. of Ratings
Success Rate
Avg Return
Oracle
Sep 13, 2026
Bearish
1Ratings
100%
+12.70%
Invesco QQQ Trust
Sep 13, 2026
Bearish
2Ratings
100%
+3.30%
State Street SPDR S&P 500 ETF Trust
Sep 17, 2026
Bearish
2Ratings
100%
+0.70%
Moderna
Oct 05, 2026
Bearish
2Ratings
50%
+21.65%
SpaceX
Oct 09, 2026
Bearish
5Ratings
60%
+5.08%
POET Technologies
Oct 13, 2026
Bullish
3Ratings
0%
-30.47%
Liquidia Technologies
Oct 14, 2026
Bearish
1Ratings
0%
-32.70%
Micron
Oct 15, 2026
Bullish
4Ratings
0%
-13.08%
Meta Platforms
Oct 22, 2026
Bullish
1Ratings
0%
-5.20%
CoreWeave
Oct 22, 2026
Bearish
3Ratings
100%
+16.90%
List of latest recommendations made by EpicComeback. Click to expand and see EpicComeback's performance on a particular stock
Disclaimer: TipRanks collects ratings of bloggers by scanning publicly available reports on financial websites and by receiving reports directly from the bloggers or from our users. The information displayed might not be accurate or up to date. The displayed ratings are made entirely at the sole discretion of the bloggers. TipRanks holds no liability over the bloggers information or opinions expressed on the site.